Recognizing and treating social anxiety disorder

Cleveland Clinic Journal of Medicine

Volumn 68, Issue 7, 2001, Pages 649-657

  Muzina, David J ^a   El Sayegh, Samar ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN RECEPTOR; CITALOPRAM; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; GABAPENTIN; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; PHENELZINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADRENERGIC SYSTEM; ANXIETY NEUROSIS; AVOIDANCE BEHAVIOR; CHEMORECEPTOR; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FAMILIAL DISEASE; GROWTH HORMONE DEFICIENCY; HEREDITY; HUMAN; MENTAL DISEASE; PANIC; PERSONALITY DISORDER; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RECEPTOR SENSITIVITY; REVIEW; SCREENING TEST; SEROTONINERGIC SYSTEM; SOCIAL BEHAVIOR; SOCIOPATHY; SUBSTANCE ABUSE; SYMPATHECTOMY; SYMPTOMATOLOGY;

EID: 0034942696     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.68.7.649     Document Type: Review

References (36)

1. Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 1998; 59(suppl 17):54-60.
2. Westenberg HG. The nature of social anxiety disorder. J Clin Psychiatry 1998; 59(suppl 17):20-24.
3. Haug TT, Hellstrom K, Blomhoff S, et al. The treatment of social phobia in general practice. Is exposure therapy feasible? Fam Pract 2000; 17:114-118.
4. Scott EL, Heimberg RG, Social phobia: an update on treatment. Psychiatry Ann 2000; 30:678-686.
5. Fones CS, Manfro GG, Pollack MH. Social phobia: an update. Harv Rev Psychiatry 1998;5:247-259.
6. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, 1994.
8. Elliot WH, Reifler B. Social anxiety disorder. A guide for primary care physicians. North Carolina Med J 2000; 61 (3):176-178.
9. Lamberg L. Social phobia. Not just another name for shyness. JAMA 1998; 280:685-686.
10. Stein MR, Chavira DA. Subtypes of social phobia and comorbidity with depression and other anxiety disorders. J Affect Disord 1998; 50:S11-S16.
11. Brunello N, den Boer JA, Judd LL, et al. Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J Affect Disord 2000; 60:61-74.
12. Sareen L, Stein M. A review of the epidemiology and approaches to the treatment of social anxiety disorder. Drugs 2000; 59.497-509.
13. Stravynski A, Greenberg D. The treatment of social phobia: a critical assessment. Acta Psychiatr Scand 1998; 98:171-181.
14. Bruce TJ, Saeed SA. Social anxiety disorder: A common, underrecognized mental disorder. Am Fam Physician 1999; 60.2311-2322.
15. Stein MB, Torgrud LJ, Walker JR. Social phobia symptoms, subtypes, and severity: findings from a community survey. Arch Gen Psychiatry 2000; 57:1046-1052.
16. Kasper S. Social phobia: The nature of the disorder J Affect Disord 1998; 50(suppl 1):S3-S9.
17. Stein DJ, Bouwer C. Blushing and social phobia. A neuroethological speculation. Med Hypotheses 1997; 49:101-108.
18. Turner SM, Beidel DC, Dancv CV, et al. An empirically derived inventory to measure social fears and anxiety The Social Phobia and Anxiety Inventory. Psychological Assessment. A Journal of Consulting and Clinical Psychology 1989; 1:35-40.
19. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987; 22:141-173.
20. Montgomery SA, Social phobia: diagnosis, severity and implications for treatment Eur Arch Psychiatry Clin Neurosci 1999, 249(suppl 1):S1-S6.
21. Lecrubier Y. Comorbidity in social anxiety disorder: impact on disease burden and management. J Clin Psychiatry 1998; 59(suppl 17):33-37.
22. Kaplan HI, Sadock BJ. Comprehensive textbook of psychiatry. 6th ed. Vol. 1. Baltimore: Williams & Wilkins; 1989:1204-1217.
23. Lieb R, Wittchen HU, Hofler M, Fuetsch M, Stein MB, Merikangas KR. Parental psychopathology, parenting styles, and the risk of social phobia in offspring: a prospective-longitudinal community study. Arch Gen Psychiatry 2000; 57:859-866.
24. Bell CJ, Malizia AL, Nutt DJ. The neurobiology of social phobia. Eur Arch Psychiatry Clin Neurosci 1999; 249(suppl 1):S11-S18.
25. Nutt DJ, Bell CJ, Malizia AL. Brain mechanisms of social anxiety disorder. J Clin Psychiatry 1998; 59(suppl 17):4-11.
26. Tiihonen J, Kuikka J, Bergstrorn K, Lepola U, Koponen H, Leinonen E. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 1997; 154:239-242.
27. Schneider F, Weiss U, Kessler C, et al. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 1999; 45:863-871.
28. Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA 1998; 280:708-713.
29. Bouwer C, Stein DJ. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia. J Affect Disord 1998; 49:79-82
30. Davidson JR. Pharmacotherapy of social anxiety disorder. J Clin Psychiatry 1998; 59(suppl 17):47-53.
31. Altamura AC, Pioli R, Vitto M, Mannu P. Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders. Int Clin Psychopharmacol 1999; 14:239-245.
32. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342:1462-1470.
33. Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999; 19:341-348.
34. Telaranta T. Treatment of social phobia by endoscopic thoracic sympathicotomy. Eur J Surg Suppl 1998, 580:27-32.
35. Ballenger JC. Anxiety disorders in adults. Biol Psychiatry 1999; 46:1579-1591.
36. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000; 283.2529-2536.